Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Amazon.com, Inc. (AMZN) -- Ignore unavailable to you. Want to Upgrade?

To: H James Morris who wrote (105117)	6/19/2000 12:11:00 PM
From: Bob Kim	Respond to of 164684

HJ, I don't know if he's a risk taker, but he can't sell any unless he downgrades the stock first.

To: H James Morris who wrote (105117)	6/19/2000 5:36:00 PM
From: Danny	Respond to of 164684

What heck is going on with RBAK? This is the only stock I happened to buy at the very bottom during this tech crash and come back huge. If this thing hits 150, I will sell some shares to take some profit. Can't resist. Another close performer is SCMR, but I didn't get in at the absolute bottom, with an average around low 70s on that one.

To: H James Morris who wrote (105117)	6/19/2000 10:03:00 PM
From: allen menglin chen	Read Replies (1) \| Respond to of 164684

Nice genome programs on TV this week, every night! --> Charlie Rose Special Edition: Mapping the Human Genome Business Wire - June 16, 2000 18:16 Jump to first matched term NEW YORK--(ENTERTAINMENT WIRE)--June 16, 2000--The human genome is referred to in the scientific community as the book of human life. The race is on to decipher this complex book and the stakes are huge. This week, Charlie Rose explores the scientific and ethical issues surrounding "Mapping the Human Genome" in a fascinating series of interviews spotlighting the key players in what many believe will be one of the greatest achievements of our time. Charlie Rose airs weeknights at 11:00 p.m. on PBS (check local listings) Monday, June 19: Dr. Craig Venter, Chairman and Chief Scientific Officer, Celera Genomics Tuesday, June 20: Dr. Francis Collins, Director, National Human Genome Research Institute Wednesday, June 21: Dr. James Watson, President, Cold Spring Harbor Laboratory; Dr. Harold Varmus, President & CEO, Memorial Sloan-Kettering Cancer Center; Arnold Levine, President and Heilbrunn Professor in Cancer Biology, Rockefeller University; Dr. Savio Woo, President, American Society of Gene Therapy Thursday, June 22: William Haseltine, CEO and Chairman, Human Genome Sciences, Inc.; Viren Mehta, Managing Partner, Mehta Partners Global Healthcare Investments; Nicholas Wade, Science Writer, The New York Times; Richard Preston, Author/Contributor New Yorker magazine; Dr. Arthur Caplan, Director, Center for Bioethics, University of Pennsylvania Friday, June 23: Implications for the Future CONTACT: Thirteen/WNET, New York Kellie Specter, 212/560-3009 specter@thirteen.org marketwatch.newsalert.com